Determining the Impact of the Health Promotion Program for Women with Breast Cancer on the Quality of Life, Hope and Family Support During Surgery and Chemotherapy

Determining the Effect of Health Promotion Educational Support Program on the Quality of Life, Hope and Family Support of Women with Breast Cancer in the Stage of Surgery and Chemotherapy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230510058141N1

Enrollment

304

Registered

2023-08-21

Start date

2023-08-23

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant Neoplasm of Breast

Interventions

Intervention 1: Intervention group:The intervention includes the implementation of the health promotion program. This program consists of:Holding at least one training session for 30 minutes to justif

Eligibility

Sex/Gender

Female

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: The patient is a new case of breast cancer. She is a candidate for mastectomy surgery or a candidate for a chemotherapy protocol. The patient is female. The patient must be between 25 and 65 years old. Be an Iranian patient. The patient should be able to read and write in Persian language.

Exclusion criteria

Exclusion criteria: Does not Agree to Participate in the Research.

Design outcomes

Primary

Measure	Time frame
The score obtained from the EORCT QLQ30 quality of life questionnaire. Timepoint: In surgery patients: at times (discharge day) 0 and 6 weeks after surgery and in chemotherapy patients at times 0 (first session of chemotherapy), one week later and 3 months later. Method of measurement: EORCT quality of life QLQ c30 questionnaire.;Hope: the score obtained from the Hearth Hope Index tool. Timepoint: In surgery patients: at times (discharge day) 0 and 6 weeks after surgery and in chemotherapy patients at times 0 (first session of chemotherapy), one week later and 3 months later. Method of measurement: Hearth Hope Index tool.;Family support: score obtained from the ICE-FPSQ Perceived Family Support Questionnaire. Timepoint: In surgery patients: at times (discharge day) 0 and 6 weeks after surgery and in chemotherapy patients at times 0 (first session of chemotherapy), one week later and 3 months later. Method of measurement: ICE-FPSQ Perceived Family Support Questionnaire.	—

Measure

Time frame

The score obtained from the EORCT QLQ30 quality of life questionnaire. Timepoint: In surgery patients: at times (discharge day) 0 and 6 weeks after surgery and in chemotherapy patients at times 0 (first session of chemotherapy), one week later and 3 months later. Method of measurement: EORCT quality of life QLQ c30 questionnaire.;Hope: the score obtained from the Hearth Hope Index tool. Timepoint: In surgery patients: at times (discharge day) 0 and 6 weeks after surgery and in chemotherapy patients at times 0 (first session of chemotherapy), one week later and 3 months later. Method of measurement: Hearth Hope Index tool.;Family support: score obtained from the ICE-FPSQ Perceived Family Support Questionnaire. Timepoint: In surgery patients: at times (discharge day) 0 and 6 weeks after surgery and in chemotherapy patients at times 0 (first session of chemotherapy), one week later and 3 months later. Method of measurement: ICE-FPSQ Perceived Family Support Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamane Raffe

Mashhad University of Medical Sciences

Rafes991@mums.ac.ir+98 51 3890 9438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026